Janssen Scientific Affairs, LLC clinical trials

A subsidiary of Johnson & Johnson

The registry lists 41 studies whose lead sponsor is Janssen Scientific Affairs, LLC. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.

Studies

Recruiting first, then most recently updated. Showing 41 of 41. All Johnson & Johnson studies →

• A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative ColitisRecruitingNCT04372108

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple MyelomaAvailableNCT05346835

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Psoriasis Longitudinal Assessment and RegistryActive, not recruitingNCT00508547

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-WorldCompletedNCT04276441

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment OptionsApproved for marketingNCT03825484

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Safety and Efficacy of Adalimumab Versus Ustekinumab for One YearCompletedNCT03464136Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformCompletedNCT02431702Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) PopulationCompletedNCT06052319

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Sustainable Early Episode Clinic Study (SEEC)CompletedNCT03571685Not applicable

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple MyelomaCompletedNCT05347485Phase 2

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight GainCompletedNCT04442737Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel DiseaseTerminatedNCT02566889Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)CompletedNCT01804166Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of CareCompletedNCT03227861Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Velcade (Bortezomib) Consolidation After TransplantCompletedNCT01539083Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy ParticipantsCompletedNCT02561923Phase 1

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)CompletedNCT01701817

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior AssessmentCompletedNCT03085108

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult ParticipantsCompletedNCT02984852Phase 1

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Multiple Myeloma Patient RegistryTerminatedNCT03180853

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) TolerabilityCompletedNCT02663193

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple MyelomaCompletedNCT02951819Phase 2

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid ArthritisCompletedNCT02728934

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Quantify Use of Anticoagulation to Improve Management of Atrial FibrillationTerminatedNCT03382613

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)CompletedNCT02600741

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Smartphones to Improve Rivaroxaban ADHEREnce in Atrial FibrillationCompletedNCT02996435Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy ParticipantsCompletedNCT02307864Phase 1

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenCompletedNCT00855335Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency DepartmentCompletedNCT02584660Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)WithdrawnNCT01631513Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary InterventionCompletedNCT01830543Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation TherapyCompletedNCT01729871Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsCompletedNCT01939496Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)CompletedNCT01165710

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Pharmacokinetics Study of Oral Rivaroxaban in Healthy ParticipantsCompletedNCT01464450Phase 1

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver TransplantCompletedNCT02165189Phase 2

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With SimeprevirCompletedNCT02103699

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedCompletedNCT01157351Phase 4

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective DisorderCompletedNCT01193153Phase 3

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy VolunteersCompletedNCT01947920Phase 1

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC

• Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health OrganizationsCompletedNCT01181960

  Sponsor listed in the registry: Janssen Scientific Affairs, LLC